Mitani Yoshihide

2018 - 2021 Contribution of vascular smooth muscle cells and inflammation to the development of occlusive pulmonary vascular disease

2017 - 2020 Role of BMPR2 mutation in Pulmonary Hypertension in Rats

2017 - 2020 Analysis of TRPV channel in experimantal pulmonary hypertension and treatment

2016 - 2019 A study of unction of an extracellular matrix molecule which could modulate pathophysiology of Kawasaki Disease.

2016 - 2019 Development of therapeutic agent for fibrotic vascular occlusion in pulmonary arterial hypertension

2015 - 2018 New treatment for pulmonary arterial hypertension targeting on inflammation-dedifferentiation pathway

2014 - 2017 Role of inflammatory mechanism in the experimental model of pulmonary arterial hypertension

2012 - 2015 Molecular mechanisms involved in the pathogenesis of occlusive pulmonary vasculopathy

2012 - 2015 pulmonary hypertension and hydrogen sulfate

2011 - 2013 Induction of pulmonary hypertension by inflammatory stimuli in mice with genetically reduced BMPR2

2009 - 2011 Role of IL-6-Th17/Treg system in the development of experimental pulmonary hypertension

2009 - 2011 Therapeutic target for pulmonary hypertension based on coagulative and inflammatory cascade analysis

2007 - 2008 Molecular basis of pulmonary hypertension using mice deficient ina causative gene and an oxidant stress-related gene

2004 - 2005 Treatment of pulmonary hypertension by retinoid

2004 - 2005 Regenerative therapy against pulmonary hypertension by using bone marrow-derived stem cells

2003 - 2004 骨形成タンパク遺伝子導入による実験的肺高血圧治療

2002 - 2004 Important role of inflammation on drug induced pulmonary hypertension

2002 - 2003 Therapy of experimental pulmonary hypertension by cyclic GMP related gene transfer